ArticleNPJ science of food2025
Initial allergenicity assessment of Ulva sp. seaweed flour.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06452381 (Towards Sustainable Food Systems), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Towards Sustainable Food Systems: Allergenicity Assessment of Green Marine Macroalga Ulva sp.
Who cites it
1 citing paper in PubMed.
- Red Seaweed-Derived Phycobiliproteins: Marine Bioactive Colorants with Functional Health Properties.Marine drugs · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Ulva sp. is a green marine macroalga and a promising yet underexplored sustainable food source, with limited research on its allergenicity. This study evaluated the allergenic potential of Ulva sp. demineralized biomass flour (Ulva-DBF) using a weight-of-evidence approach inspired by regulatory assessments for novel foods, combining literature review, proteomic analysis, and a pilot clinical trial. Literature revealed no documented Ulva allergenicity. Proteomic analysis identified a few putative allergens, with estimated allergenic potential below 0.02%. In a pilot clinical trial (registered at ClinicalTrials.gov, Identifier: NCT06452381; First Posted Date: June 11, 2024), 31 participants consumed Ulva-DBF. No allergic reactions occurred, although 16.6% reported gastrointestinal discomfort. These findings represent a preliminary evaluation phase before widespread exposure. Nevertheless, large-scale consumption remains the most effective way to assess public health risks associated with any food. As we seek innovative and sustainable food solutions, post-marketing monitoring is vital to ensure their safety.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.